Adebrelimab Combined with Apatinib and Gemcitabine and Cisplatin (GP) First-line Treatment for Unresectable Biliary Tract Carcinoma

Abroad (travel likely)RecruitingPHASE2

Conditions

Unresectable Biliary Tract Carcinoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

HeNan, Zhengzhou, China
Contact: Study coordinator (Ying Liu, MD) · yaya7207@126.com · +8613783604602

Study leads

Ying Liu, MD
Principal Investigator
Study Principal Investigator Henan Cancer Hospital

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors

Advanced Solid Tumors · Genital Neoplasm, Female · Urogenital Neoplasms

Abroad (travel likely)RecruitingPHASE1, PHASE2

Loma Linda, United States · Sacramento, United States

Tripegfilgrastim Trial to Reduce the Risk of Severe Neutropenia in Patients With Unresectable Pancreaticobiliary Cancers

Unresectable Pancreatic Cancer · Unresectable Bile Duct Carcinoma · Unresectable Biliary Tract Carcinoma

Abroad (travel likely)RecruitingPHASE2

Goyang-si, South Korea

Trastuzumab Plus Chemotherapy vs Chemotherapy Alone in First-line HER2 Positive Advanced Biliary Tract Cancer Patients

Biliary Tract Cancer · HER2-positive Cancer · Advanced Cancer

Abroad (travel likely)RecruitingPHASE3

Muzaffarpur, India · Mumbai, India

Phase II Study of Neoadjuvant Tislelizumab Plus Radiotherapy and GP Chemotherapy for Borderline/Unresectable Hilar Cholangiocarcinoma

Cholangiocarcinoma · Hilar Cholangiocarcinoma · Bile Duct Cancer

Abroad (travel likely)RecruitingPHASE2

Jinan, China